Trials / Completed
CompletedNCT00160121
Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease
A Phase IV, Open-Label, Multi-Center Trial Evaluating the Efficacy of Fosrenol Compared to Existing Therapy in Adults With End Stage Renal Disease Treated for Hyperphosphatemia
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 2,500 (planned)
- Sponsor
- Shire · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test how well lanthanum carbonate reduces the pre-dialysis level of serum phosphorus in subjects undergoing dialysis due to end stage renal disease and to determine the patient and physician's satisfaction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lanthanum carbonate |
Timeline
- Start date
- 2005-01-10
- Primary completion
- 2005-12-13
- Completion
- 2005-12-13
- First posted
- 2005-09-12
- Last updated
- 2021-07-02
Source: ClinicalTrials.gov record NCT00160121. Inclusion in this directory is not an endorsement.